Initial experience with del Nido cardioplegia solution at a Pediatric and Congenital Cardiac Surgery Program in Brazil.
Luiz Fernando CaneoGregory S MatteAida Luiza R TurquettoLuana Marques de Carvalho PegolloMaria Clara Amato MiglioliGisele T de SouzaLuciana Patrick AmatoLeonardo A MianaMaria Raquel B MassotiJuliano G PenhaCarla TanamatiMarcelo B JateneFabio B JatenePublished in: Perfusion (2021)
In our congenital cardiac surgery population, del Nido cardioplegia strategy was associated with less ventricular dysfunction with LCOS, a lower VIS and decreased ICU LOS compared with patients that received our standard myocardial protection using a modified St. Thomas' solution. Despite the limitation of this study, including its retrospective nature and cohort size, these data supported our transition to incorporate del Nido cardioplegia solution with a mandatory reperfusion period as the preferred myocardial protection method in our program.
Keyphrases
- cardiac surgery
- left ventricular
- acute kidney injury
- end stage renal disease
- ejection fraction
- quality improvement
- chronic kidney disease
- newly diagnosed
- prognostic factors
- intensive care unit
- heart failure
- oxidative stress
- electronic health record
- young adults
- cross sectional
- machine learning
- deep learning
- big data
- atrial fibrillation
- acute coronary syndrome